基于术中血流动力学监测数据的术中大量输血需求预测模型的开发与验证
本研究为预后研究,利用首尔大学医院2016–2019年17 986例及Boramae医疗中心2020–2021年494例接受有创血压监测手术患者的数据,开发并验证基于深度学习的术中大量输血实时预测模型。大量输血定义为1小时内输注3单位及以上红细胞。实时模型(术前+术中参数)在内部验证集AUROC 0.972(95%CI 0.968–0.976),显著优于仅用术前变量的模型AUROC 0.824(95%CI 0.813–0.834;P<.001),外部验证AUROC 0.943(95%CI 0.919–0.961)。大量输血指数>90百分位者较<80百分位者大量输血风险高47.5倍。作者认为该模型预测准确性高,可支持高危患者早期干预。
要点
- 实时预测模型(术前+术中血流动力学参数)内部验证AUROC 0.972(95%CI 0.968–0.976),显著优于术前模型AUROC 0.824(95%CI 0.813–0.834;P<.001)。
- 外部验证(Boramae医疗中心494例)AUROC 0.943(95%CI 0.919–0.961),提示模型在外部数据中预测性能良好。
- 大量输血指数>90百分位患者较<80百分位患者大量输血风险高47.5倍。
- 模型可提前10分钟预测术中大量输血,为血液制品准备和团队调配留出时间。
- 大量输血定义为1小时内输注3单位及以上红细胞;开发队列中416例(2.3%)发生术中大量输血。
适用人群与场景
- 在首尔大学医院(2016–2019年)和Boramae医疗中心(2020–2021年)接受手术并行动脉有创血压监测的患者。
- 开发与内部验证集为首尔大学医院17 986例患者,外部验证集为Boramae医疗中心494例患者。
诊断标准与关键阈值
- 大量输血定义为1小时内输注3单位及以上红细胞。
- 大量输血指数>90百分位为最高风险组,<80百分位为较低风险组。
研究设计与关键结果
- 研究类型为预后研究,开发集17 986例(平均[SD]年龄58.65[14.81]岁;女性9036例[50.2%]),其中416例(2.3%)发生术中大量输血,平均[SD]手术时长170.99[105.03]分钟。
- 实时预测模型(术前+术中参数)内部验证AUROC 0.972(95%CI 0.968–0.976),显著优于术前预测模型AUROC 0.824(95%CI 0.813–0.834;P<.001)。
- 大量输血指数>90百分位患者较<80百分位患者大量输血风险高47.5倍。
- 外部验证集(Boramae医疗中心494例)实时预测模型AUROC 0.943(95%CI 0.919–0.961)。
证据类型、等级与局限
- 证据类型:预后研究(预测模型开发与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该实时预测模型预测准确性高,可支持对高危患者早期干预。
- 作者认为该模型提示人工智能辅助临床决策支持系统在手术领域具有较强信心。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Massive transfusion is essential to prevent complications during uncontrolled intraoperative hemorrhage. As massive transfusion requires time for blood product preparation and additional medical personnel for a team-based approach, early prediction of massive transfusion is crucial for appropriate management.
OBJECTIVE: To evaluate a real-time prediction model for massive transfusion during surgery based on the incorporation of preoperative data and intraoperative hemodynamic monitoring data.
DESIGN, SETTING, AND PARTICIPANTS: This prognostic study used data sets from patients who underwent surgery with invasive blood pressure monitoring at Seoul National University Hospital (SNUH) from 2016 to 2019 and Boramae Medical Center (BMC) from 2020 to 2021. SNUH represented the development and internal validation data sets (n = 17 986 patients), and BMC represented the external validation data sets (n = 494 patients). Data were analyzed from November 2020 to December 2021.
EXPOSURES: A deep learning-based real-time prediction model for massive transfusion.
MAIN OUTCOMES AND MEASURES: Massive transfusion was defined as a transfusion of 3 or more units of red blood cells over an hour. A preoperative prediction model for massive transfusion was developed using preoperative variables. Subsequently, a real-time prediction model using preoperative and intraoperative parameters was constructed to predict massive transfusion 10 minutes in advance. A prediction model, the massive transfusion index, calculated the risk of massive transfusion in real time.
RESULTS: Among 17 986 patients at SNUH (mean [SD] age, 58.65 [14.81] years; 9036 [50.2%] female), 416 patients (2.3%) underwent massive transfusion during the operation (mean [SD] duration of operation, 170.99 [105.03] minutes). The real-time prediction model constructed with the use of preoperative and intraoperative parameters significantly outperformed the preoperative prediction model (area under the receiver characteristic curve [AUROC], 0.972; 95% CI, 0.968-0.976 vs AUROC, 0.824; 95% CI, 0.813-0.834 in the SNUH internal validation data set; P < .001). Patients with the highest massive transfusion index (ie, >90th percentile) had a 47.5-fold increased risk for a massive transfusion compared with those with a lower massive transfusion index (ie, <80th percentile). The real-time prediction model also showed excellent performance in the external validation data set (AUROC of 0.943 [95% CI, 0.919-0.961] in BMC).
CONCLUSIONS AND RELEVANCE: The findings of this prognostic study suggest that the real-time prediction model for massive transfusion showed high accuracy of prediction performance, enabling early intervention for high-risk patients. It suggests strong confidence in artificial intelligence-assisted clinical decision support systems in the operating field.
参考来源
- Lee SM, Lee G, Kim TK, et al. Development and Validation of a Prediction Model for Need for Massive Transfusion During Surgery Using Intraoperative Hemodynamic Monitoring Data. JAMA Netw Open. 2022. PMID: 36515949. doi:10.1001/jamanetworkopen.2022.46637
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。